ONDANSETRON ZENTIVA 8 mg, orodispersible tablet 2 tablets
Active ingredients: Ondansetron
Commercialized according to BDPMDispensing in France: Prescription only
Orodispersible tablet2 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ONDANSETRON ZENTIVA 8 mg, comprimé orodispersible
- Pharmaceutical form
- comprimé orodispersible
- Route of administration
- orale
- Presentation description
- plaquette(s) polyamide PVC-Aluminium PETP : copolymère de polytéréphta.d'éthlè.glycol et de diéthylè.glycol aluminium de 2 comprimé(s)
- Marketing authorisation holder
- ZENTIVA FRANCE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 7 Dec 2018
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68663863CIP73008782CIP133400930087824Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ONDANSÉTRONcomprimé | 8,00 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.